Ace the Indiana MPJE 2026 – Prescription for Success in Pharmacy Law!

Suboxone, which contains buprenorphine and naloxone, is a medication used primarily for the treatment of opioid addiction. In order to prescribe this medication, healthcare providers must obtain a DATA-waived DEA number, which signifies that they are certified to prescribe controlled substances specifically for this purpose. This requirement is part of the regulations established under the Drug Addiction Treatment Act (DATA) of 2000, designed to ensure that patients receive appropriate care for substance use disorders while also regulating the prescription of potentially abuse-prone medications.

The need for a DATA-waived DEA number makes it clear that extra qualifications are necessary for providers who wish to prescribe treatment for opioid addiction. This regulation reflects the complexity and seriousness of prescribing medications that have the potential for misuse and dependence, helping to ensure that only qualified practitioners manage such prescriptions.